RTW INVESTMENTS, LP - 07 May 2021 Form 4 Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Role
10%+ Owner
Signature
RTW Investments, LP By: /s/ Roderick Wong, Managing Partner
Issuer symbol
TARS
Transactions as of
07 May 2021
Net transactions value
-$13,491,000
Form type
4
Filing time
07 May 2021, 20:01:03 UTC
Previous filing
08 Nov 2022
Next filing
13 May 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARS Common Stock Sale $13,491,000 -450,000 -18% $29.98 2,013,601 07 May 2021 By RTW F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

RTW INVESTMENTS, LP is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The securities reported herein may be deemed beneficially owned by each of: (i) RTW Investments, LP ("RTW"), which is deemed the beneficial owner of shares held by RTW Master Fund, Ltd., RTW Venture Fund Limited and RTW Innovation Master Fund, Ltd. (the "Funds"), which are investment funds managed by RTW, and (ii) Roderick Wong, M.D who serves as the Managing Partner and Chief Investment Officer of RTW. Dr. Wong exercises voting and dispositive control over the securities held by RTW and is therefore deemed to be a beneficial owner of securities owned or controlled by RTW. Dr. Wong disclaims beneficial ownership of the reported securities held by the Funds, except to the extent of his pecuniary interest therein.